 | • レポートコード：D0GIR-01441 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ペット用駆虫薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。ペット用駆虫薬の種類別市場規模（外部、内部、コンポジット、インジェクション）、用途別市場規模（犬、猫、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Elanco、Jeffers、Chanelle Group、Boehringer Ingelheim、First Priority、Ceva Sante Animale、Merck Animal Health、Durvet、Dechra、Manna Pro Products、Zoetis、Ourofino、Virbac、TTK Healthcare、Vetoquinol ・地域別グローバル市場分析 2015年-2020年 ・ペット用駆虫薬の北米市場（アメリカ、カナダ、メキシコ） ・ペット用駆虫薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ペット用駆虫薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ペット用駆虫薬の南米市場（ブラジル、アルゼンチン） ・ペット用駆虫薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：外部、内部、コンポジット、インジェクション ・用途別分析：犬、猫、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Pet Anthelmintic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Pet Anthelmintic Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Pet Anthelmintic Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Pet Anthelmintic Drugs market has been segmented into:
External
Internal
Composite
Injection
By Application, Pet Anthelmintic Drugs has been segmented into:
Dog
Cat
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pet Anthelmintic Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Pet Anthelmintic Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pet Anthelmintic Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Pet Anthelmintic Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Pet Anthelmintic Drugs Market Share Analysis
Pet Anthelmintic Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pet Anthelmintic Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pet Anthelmintic Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Pet Anthelmintic Drugs are:
Elanco
Jeffers
Chanelle Group
Boehringer Ingelheim
First Priority
Ceva Sante Animale
Merck Animal Health
Durvet
Dechra
Manna Pro Products
Zoetis
Ourofino
Virbac
TTK Healthcare
Vetoquinol
Among other players domestic and global, Pet Anthelmintic Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Pet Anthelmintic Drugs Market Overview
1.1 Product Overview and Scope of Pet Anthelmintic Drugs
1.2 Classification of Pet Anthelmintic Drugs by Type
1.2.1 Global Pet Anthelmintic Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Pet Anthelmintic Drugs Revenue Market Share by Type in 2019
1.2.3 External
1.2.4 Internal
1.2.5 Composite
1.2.6 Injection
1.3 Global Pet Anthelmintic Drugs Market by Application
1.3.1 Overview: Global Pet Anthelmintic Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Dog
1.3.3 Cat
1.3.4 Others
1.4 Global Pet Anthelmintic Drugs Market by Regions
1.4.1 Global Pet Anthelmintic Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Pet Anthelmintic Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Pet Anthelmintic Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Pet Anthelmintic Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pet Anthelmintic Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Pet Anthelmintic Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pet Anthelmintic Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Elanco
2.1.1 Elanco Details
2.1.2 Elanco Major Business
2.1.3 Elanco SWOT Analysis
2.1.4 Elanco Product and Services
2.1.5 Elanco Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Jeffers
2.2.1 Jeffers Details
2.2.2 Jeffers Major Business
2.2.3 Jeffers SWOT Analysis
2.2.4 Jeffers Product and Services
2.2.5 Jeffers Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Chanelle Group
2.3.1 Chanelle Group Details
2.3.2 Chanelle Group Major Business
2.3.3 Chanelle Group SWOT Analysis
2.3.4 Chanelle Group Product and Services
2.3.5 Chanelle Group Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Boehringer Ingelheim
2.4.1 Boehringer Ingelheim Details
2.4.2 Boehringer Ingelheim Major Business
2.4.3 Boehringer Ingelheim SWOT Analysis
2.4.4 Boehringer Ingelheim Product and Services
2.4.5 Boehringer Ingelheim Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 First Priority
2.5.1 First Priority Details
2.5.2 First Priority Major Business
2.5.3 First Priority SWOT Analysis
2.5.4 First Priority Product and Services
2.5.5 First Priority Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Ceva Sante Animale
2.6.1 Ceva Sante Animale Details
2.6.2 Ceva Sante Animale Major Business
2.6.3 Ceva Sante Animale Product and Services
2.6.4 Ceva Sante Animale Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck Animal Health
2.7.1 Merck Animal Health Details
2.7.2 Merck Animal Health Major Business
2.7.3 Merck Animal Health Product and Services
2.7.4 Merck Animal Health Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Durvet
2.8.1 Durvet Details
2.8.2 Durvet Major Business
2.8.3 Durvet Product and Services
2.8.4 Durvet Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Dechra
2.9.1 Dechra Details
2.9.2 Dechra Major Business
2.9.3 Dechra Product and Services
2.9.4 Dechra Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 Manna Pro Products
2.10.1 Manna Pro Products Details
2.10.2 Manna Pro Products Major Business
2.10.3 Manna Pro Products Product and Services
2.10.4 Manna Pro Products Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.11 Zoetis
2.11.1 Zoetis Details
2.11.2 Zoetis Major Business
2.11.3 Zoetis Product and Services
2.11.4 Zoetis Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.12 Ourofino
2.12.1 Ourofino Details
2.12.2 Ourofino Major Business
2.12.3 Ourofino Product and Services
2.12.4 Ourofino Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.13 Virbac
2.13.1 Virbac Details
2.13.2 Virbac Major Business
2.13.3 Virbac Product and Services
2.13.4 Virbac Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.14 TTK Healthcare
2.14.1 TTK Healthcare Details
2.14.2 TTK Healthcare Major Business
2.14.3 TTK Healthcare Product and Services
2.14.4 TTK Healthcare Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.15 Vetoquinol
2.15.1 Vetoquinol Details
2.15.2 Vetoquinol Major Business
2.15.3 Vetoquinol Product and Services
2.15.4 Vetoquinol Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Pet Anthelmintic Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Pet Anthelmintic Drugs Players Market Share
3.2.2 Top 10 Pet Anthelmintic Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Pet Anthelmintic Drugs Revenue and Market Share by Regions
4.2 North America Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
5 North America Pet Anthelmintic Drugs Revenue by Countries
5.1 North America Pet Anthelmintic Drugs Revenue by Countries (2015-2020)
5.2 USA Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
6 Europe Pet Anthelmintic Drugs Revenue by Countries
6.1 Europe Pet Anthelmintic Drugs Revenue by Countries (2015-2020)
6.2 Germany Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
6.4 France Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Pet Anthelmintic Drugs Revenue by Countries
7.1 Asia-Pacific Pet Anthelmintic Drugs Revenue by Countries (2015-2020)
7.2 China Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
7.5 India Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
8 South America Pet Anthelmintic Drugs Revenue by Countries
8.1 South America Pet Anthelmintic Drugs Revenue by Countries (2015-2020)
8.2 Brazil Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Pet Anthelmintic Drugs by Countries
9.1 Middle East & Africa Pet Anthelmintic Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Pet Anthelmintic Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Pet Anthelmintic Drugs Market Forecast by Type (2019-2024)
10.3 External Revenue Growth Rate (2015-2025)
10.4 Internal Revenue Growth Rate (2015-2025)
10.5 Composite Revenue Growth Rate (2015-2025)
10.6 Injection Revenue Growth Rate (2015-2025)
11 Global Pet Anthelmintic Drugs Market Segment by Application
11.1 Global Pet Anthelmintic Drugs Revenue Market Share by Application (2015-2020)
11.2 Pet Anthelmintic Drugs Market Forecast by Application (2019-2024)
11.3 Dog Revenue Growth (2015-2020)
11.4 Cat Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Pet Anthelmintic Drugs Market Size Forecast (2021-2025)
12.1 Global Pet Anthelmintic Drugs Market Size Forecast (2021-2025)
12.2 Global Pet Anthelmintic Drugs Market Forecast by Regions (2021-2025)
12.3 North America Pet Anthelmintic Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Pet Anthelmintic Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Pet Anthelmintic Drugs Revenue Market Forecast (2021-2025)
12.6 South America Pet Anthelmintic Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Pet Anthelmintic Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Pet Anthelmintic Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pet Anthelmintic Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pet Anthelmintic Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Pet Anthelmintic Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Pet Anthelmintic Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Elanco Corporate Information, Location and Competitors
Table 7. Elanco Pet Anthelmintic Drugs Major Business
Table 8. Elanco Pet Anthelmintic Drugs Total Revenue (USD Million) (2017-2018)
Table 9. Elanco SWOT Analysis
Table 10. Elanco Pet Anthelmintic Drugs Product and Solutions
Table 11. Elanco Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Jeffers Corporate Information, Location and Competitors
Table 13. Jeffers Pet Anthelmintic Drugs Major Business
Table 14. Jeffers Pet Anthelmintic Drugs Total Revenue (USD Million) (2018-2019)
Table 15. Jeffers SWOT Analysis
Table 16. Jeffers Pet Anthelmintic Drugs Product and Solutions
Table 17. Jeffers Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Chanelle Group Corporate Information, Location and Competitors
Table 19. Chanelle Group Pet Anthelmintic Drugs Major Business
Table 20. Chanelle Group Pet Anthelmintic Drugs Total Revenue (USD Million) (2017-2018)
Table 21. Chanelle Group SWOT Analysis
Table 22. Chanelle Group Pet Anthelmintic Drugs Product and Solutions
Table 23. Chanelle Group Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 25. Boehringer Ingelheim Pet Anthelmintic Drugs Major Business
Table 26. Boehringer Ingelheim Pet Anthelmintic Drugs Total Revenue (USD Million) (2017-2018)
Table 27. Boehringer Ingelheim SWOT Analysis
Table 28. Boehringer Ingelheim Pet Anthelmintic Drugs Product and Solutions
Table 29. Boehringer Ingelheim Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. First Priority Corporate Information, Location and Competitors
Table 31. First Priority Pet Anthelmintic Drugs Major Business
Table 32. First Priority Pet Anthelmintic Drugs Total Revenue (USD Million) (2017-2018)
Table 33. First Priority SWOT Analysis
Table 34. First Priority Pet Anthelmintic Drugs Product and Solutions
Table 35. First Priority Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Ceva Sante Animale Corporate Information, Location and Competitors
Table 37. Ceva Sante Animale Pet Anthelmintic Drugs Major Business
Table 38. Ceva Sante Animale Pet Anthelmintic Drugs Total Revenue (USD Million) (2017-2018)
Table 39. Ceva Sante Animale SWOT Analysis
Table 40. Ceva Sante Animale Pet Anthelmintic Drugs Product and Solutions
Table 41. Ceva Sante Animale Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Merck Animal Health Corporate Information, Location and Competitors
Table 43. Merck Animal Health Pet Anthelmintic Drugs Major Business
Table 44. Merck Animal Health Pet Anthelmintic Drugs Total Revenue (USD Million) (2017-2018)
Table 45. Merck Animal Health SWOT Analysis
Table 46. Merck Animal Health Pet Anthelmintic Drugs Product and Solutions
Table 47. Merck Animal Health Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Durvet Corporate Information, Location and Competitors
Table 49. Durvet Pet Anthelmintic Drugs Major Business
Table 50. Durvet Pet Anthelmintic Drugs Total Revenue (USD Million) (2017-2018)
Table 51. Durvet SWOT Analysis
Table 52. Durvet Pet Anthelmintic Drugs Product and Solutions
Table 53. Durvet Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Dechra Corporate Information, Location and Competitors
Table 55. Dechra Pet Anthelmintic Drugs Major Business
Table 56. Dechra Pet Anthelmintic Drugs Total Revenue (USD Million) (2017-2018)
Table 57. Dechra SWOT Analysis
Table 58. Dechra Pet Anthelmintic Drugs Product and Solutions
Table 59. Dechra Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Manna Pro Products Corporate Information, Location and Competitors
Table 61. Manna Pro Products Pet Anthelmintic Drugs Major Business
Table 62. Manna Pro Products Pet Anthelmintic Drugs Total Revenue (USD Million) (2017-2018)
Table 63. Manna Pro Products SWOT Analysis
Table 64. Manna Pro Products Pet Anthelmintic Drugs Product and Solutions
Table 65. Manna Pro Products Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Zoetis Corporate Information, Location and Competitors
Table 67. Zoetis Pet Anthelmintic Drugs Major Business
Table 68. Zoetis Pet Anthelmintic Drugs Total Revenue (USD Million) (2017-2018)
Table 69. Zoetis SWOT Analysis
Table 70. Zoetis Pet Anthelmintic Drugs Product and Solutions
Table 71. Zoetis Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Ourofino Corporate Information, Location and Competitors
Table 73. Ourofino Pet Anthelmintic Drugs Major Business
Table 74. Ourofino Pet Anthelmintic Drugs Total Revenue (USD Million) (2017-2018)
Table 75. Ourofino SWOT Analysis
Table 76. Ourofino Pet Anthelmintic Drugs Product and Solutions
Table 77. Ourofino Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Virbac Corporate Information, Location and Competitors
Table 79. Virbac Pet Anthelmintic Drugs Major Business
Table 80. Virbac Pet Anthelmintic Drugs Total Revenue (USD Million) (2017-2018)
Table 81. Virbac SWOT Analysis
Table 82. Virbac Pet Anthelmintic Drugs Product and Solutions
Table 83. Virbac Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. TTK Healthcare Corporate Information, Location and Competitors
Table 85. TTK Healthcare Pet Anthelmintic Drugs Major Business
Table 86. TTK Healthcare Pet Anthelmintic Drugs Total Revenue (USD Million) (2017-2018)
Table 87. TTK Healthcare SWOT Analysis
Table 88. TTK Healthcare Pet Anthelmintic Drugs Product and Solutions
Table 89. TTK Healthcare Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Vetoquinol Corporate Information, Location and Competitors
Table 91. Vetoquinol Pet Anthelmintic Drugs Major Business
Table 92. Vetoquinol Pet Anthelmintic Drugs Total Revenue (USD Million) (2017-2018)
Table 93. Vetoquinol SWOT Analysis
Table 94. Vetoquinol Pet Anthelmintic Drugs Product and Solutions
Table 95. Vetoquinol Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Global Pet Anthelmintic Drugs Revenue (Million USD) by Players (2015-2020)
Table 97. Global Pet Anthelmintic Drugs Revenue Share by Players (2015-2020)
Table 98. Global Pet Anthelmintic Drugs Revenue (Million USD) by Regions (2015-2020)
Table 99. Global Pet Anthelmintic Drugs Revenue Market Share by Regions (2015-2020)
Table 100. North America Pet Anthelmintic Drugs Revenue by Countries (2015-2020)
Table 101. North America Pet Anthelmintic Drugs Revenue Market Share by Countries (2015-2020)
Table 102. Europe Pet Anthelmintic Drugs Revenue (Million USD) by Countries (2015-2020)
Table 103. Asia-Pacific Pet Anthelmintic Drugs Revenue (Million USD) by Countries (2015-2020)
Table 104. South America Pet Anthelmintic Drugs Revenue by Countries (2015-2020)
Table 105. South America Pet Anthelmintic Drugs Revenue Market Share by Countries (2015-2020)
Table 106. Middle East and Africa Pet Anthelmintic Drugs Revenue (Million USD) by Countries (2015-2020)
Table 107. Middle East and Africa Pet Anthelmintic Drugs Revenue Market Share by Countries (2015-2020)
Table 108. Global Pet Anthelmintic Drugs Revenue (Million USD) by Type (2015-2020)
Table 109. Global Pet Anthelmintic Drugs Revenue Share by Type (2015-2020)
Table 110. Global Pet Anthelmintic Drugs Revenue Forecast by Type (2021-2025)
Table 111. Global Pet Anthelmintic Drugs Revenue by Application (2015-2020)
Table 112. Global Pet Anthelmintic Drugs Revenue Share by Application (2015-2020)
Table 113. Global Pet Anthelmintic Drugs Revenue Forecast by Application (2021-2025)
Table 114. Global Pet Anthelmintic Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Pet Anthelmintic Drugs Picture
Figure 2. Global Pet Anthelmintic Drugs Revenue Market Share by Type in 2019
Figure 3. External Picture
Figure 4. Internal Picture
Figure 5. Composite Picture
Figure 6. Injection Picture
Figure 7. Pet Anthelmintic Drugs Revenue Market Share by Application in 2019
Figure 8. Dog Picture
Figure 9. Cat Picture
Figure 10. Others Picture
Figure 11. Global Pet Anthelmintic Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Pet Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Pet Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Pet Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Pet Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Pet Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Pet Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Pet Anthelmintic Drugs Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Pet Anthelmintic Drugs Revenue Market Share in 2019
Figure 20. Global Top 10 Players Pet Anthelmintic Drugs Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Pet Anthelmintic Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Pet Anthelmintic Drugs Revenue Market Share by Regions (2015-2020)
Figure 24. Global Pet Anthelmintic Drugs Revenue Market Share by Regions in 2018
Figure 25. North America Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 26. Europe Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 28. South America Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 30. North America Pet Anthelmintic Drugs Revenue Market Share by Countries (2015-2020)
Figure 31. North America Pet Anthelmintic Drugs Revenue Market Share by Countries in 2019
Figure 32. USA Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 33. Canada Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 35. Europe Pet Anthelmintic Drugs Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Pet Anthelmintic Drugs Revenue Market Share by Countries in 2019
Figure 37. Germany Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 38. UK Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 39. France Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 40. Russia Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 41. Italy Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Pet Anthelmintic Drugs Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Pet Anthelmintic Drugs Revenue Market Share by Countries in 2019
Figure 44. China Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Japan Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 46. Korea Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 47. India Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 49. South America Pet Anthelmintic Drugs Revenue Market Share by Countries (2015-2020)
Figure 50. South America Pet Anthelmintic Drugs Revenue Market Share by Countries in 2019
Figure 51. Brazil Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Pet Anthelmintic Drugs Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Pet Anthelmintic Drugs Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 56. UAE Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Pet Anthelmintic Drugs Revenue and Growth Rate (2015-2020)
Figure 59. Global Pet Anthelmintic Drugs Revenue Share by Type (2015-2020)
Figure 60. Global Pet Anthelmintic Drugs Revenue Share by Type in 2019
Figure 61. Global Pet Anthelmintic Drugs Market Share Forecast by Type (2021-2025)
Figure 62. Global External Revenue Growth Rate (2015-2020)
Figure 63. Global Internal Revenue Growth Rate (2015-2020)
Figure 64. Global Composite Revenue Growth Rate (2015-2020)
Figure 65. Global Injection Revenue Growth Rate (2015-2020)
Figure 66. Global Pet Anthelmintic Drugs Revenue Share by Application (2015-2020)
Figure 67. Global Pet Anthelmintic Drugs Revenue Share by Application in 2019
Figure 68. Global Pet Anthelmintic Drugs Market Share Forecast by Application (2021-2025)
Figure 69. Global Dog Revenue Growth Rate (2015-2020)
Figure 70. Global Cat Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Pet Anthelmintic Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Pet Anthelmintic Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Pet Anthelmintic Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Pet Anthelmintic Drugs Revenue Market Forecast (2021-2025)
Figure 76. Europe Pet Anthelmintic Drugs Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Pet Anthelmintic Drugs Revenue Market Forecast (2021-2025)
Figure 78. South America Pet Anthelmintic Drugs Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Pet Anthelmintic Drugs Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
泌尿生殖器薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Genitourinary Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Genitourinary Drugs marke…- 先端巨大症・巨人症治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Acromegaly and Gigantism Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Acromegaly and…
- イソトレチノイン薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Isotretinoin Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.7% in the forecast period of 2020 to 2025 and will expected to reach USD 1276.2 million by 2025, from USD 1191.2 million in 2019. The Isotretinoin Drug…
- ポリエン抗真菌薬APIの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Polyene Antifungal Drugs API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 眼瞼炎治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Blepharitis Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…